Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in RSV immunization ...

RSV-related ARI was associated with a significant hospitalization burden in older adults, but its clinical severity was similar to that of influenza-related ARI.

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. While pregnant with her third child ...

Hospitalizations due to RSV cases in infants are reduced by up to 43% following the introduction of new maternal vaccines.

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness, according to Yale research published in JAMA Network Open.

An Austin based scientist has received a prestigious award for his research into how viruses infect us, and how to stop or slow them. Jason McLellan is structural biologist at The University of Texas ...

For older adults, the vaccine against respiratory syncytial virus (RSV) appears to be most effective in the first year after administration, according to new research that shows the benefits of the ...

New study finds adjuvanted RSVPreF3 OA vaccine triggers stronger immunity than RSVpreF in immunocompromised adults, including ...